Literature DB >> 6101296

Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.

W J McKenna, S Chetty, C M Oakley, J F Goodwin.   

Abstract

Submaximal treadmill exercise electrocardiography and 48 hour ambulatory electrocardiographic monitoring were performed in 30 patients with hypertrophic cardiomyopathy both with and without beta adrenergic blocking therapy. During ambulatory electrocardiographic monitoring 1 patient (3 percent) had no arrhythmia, 14 patients (46 percent) had supraventricular tachycardia or paroxysmal atrial fibrillation, 13 (43 percent) had multiform or paired ventricular extrasystoles and 8 (26 percent) had ventricular tachycardia. The frequency of these ventricular arrhythmias was almost identical with and without beta adrenergic blocking drugs (mean dose in "propranolol equivalents" 280 mg daily). With beta blocking therapy fewer patients had supraventricular tachycardia; however, the difference was not significant. During exercise testing 18 patients (60 percent) had ventricular extrasystoles and 3 patients (10 percent) had paired ventricular extrasystoles and the frequency was almost identical with and without beta adrenergic blocking therapy. No routine echocardiographic or hemodynamic measurement predicted the serious ventricular arrhythmias. It is concluded that asymptomatic ventricular arrhythmia is a common occurrence in patients with hypertrophic cardiomyopathy and its frequency is not reduced with beta adrenergic blocking therapy. Because occult arrhythmia may be the cause of sudden death it is important to detect it in these patients so that an effort can be made to improve prognosis with specific antiarrhythmic treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101296     DOI: 10.1016/0002-9149(80)90212-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery.

Authors:  A G Zaman; F Alamgir; T Richens; R Williams; M T Rothman; P G Mills
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 2.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

3.  Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

Authors:  W J McKenna; L Harris; G Perez; D M Krikler; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

4.  Arrhythmia in hypertrophic cardiomyopathy.

Authors: 
Journal:  Br Med J       Date:  1980-10-18

5.  Prediction of mortality and serious ventricular arrhythmia in hypertrophic cardiomyopathy. An echocardiographic study.

Authors:  Y L Doi; W J McKenna; S Chetty; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1980-08

6.  Ventricular premature beats--story petrels?

Authors:  D B Shaw
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-06

7.  Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.

Authors:  K Landmark; S Sire; E Thaulow; J P Amlie; S Nitter-Hauge
Journal:  Br Heart J       Date:  1982-07

8.  Pulmonary oedema in two parturients with hypertrophic obstructive cardiomyopathy (HOCM).

Authors:  M J Tessler; R Hudson; M Naugler-Colville; D R Biehl
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

9.  Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.

Authors:  W J McKenna; D England; Y L Doi; J E Deanfield; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

Review 10.  Ventricular arrhythmias.

Authors:  K M Kavanagh; D G Wyse
Journal:  CMAJ       Date:  1988-05-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.